Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices
NHS hospitals in England used £191,431,035 of indicative cost of Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.8% of all hospital medicines spend. That is up 38.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Salford Royal Nhs Foundation Trust | £19,347,278 |
| University College London Foundation Tr | £17,086,140 |
| The Walton Centre Nhs Foundation Trust | £9,099,773 |
| Sheffield Teaching Hospitals Nhs Trust | £8,481,878 |
| St George's Univ Hosps Foundation Nhst | £8,249,048 |
| Western Sussex Hospitals Nhs Found Trust | £6,844,605 |
| North Bristol Nhs Trust | £6,377,453 |
| University Hospital Southampton Nhs Ft | £6,229,695 |
| Cambridge Univ Hosp Nhs Foundation Trust | £5,798,363 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £5,553,593 |
The primary-care picture
Ofatumumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ofatumumab medicine page.